Showing results (411-420 of 1,558) with videos related to

Sort By:
Pageof 156
Current Pharmaceutical Design|May 17, 2019
Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?Marjorie C Argollo, Mariangela Allocca, Federica Furfaro, et al.
Optics Express|May 3, 2018
Time-resolved multispectral imaging based on an adaptive single-pixel cameraFlorian Rousset, Nicolas Ducros, Françoise Peyrin, et al.
Journal of Crohn'S & Colitis|May 19, 2023
Defining Biological Remission in Crohn's Disease: Interest, Challenges and Future DirectionsNicolas Pierre, Sophie Vieujean, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|March 15, 2020
Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel diseaseDaniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, et al.
Journal of Neural Transmission|January 1, 1986
Peripheral distribution of free dopamine and its metabolites in the ratR Favre, M de Haut, Y Dalmaz, et al.
Expert Opinion on Biological Therapy|December 19, 2019
Histological healing: should it be considered as a new outcome for ulcerative colitis?Arianna Dal Buono, Giulia Roda, Marjorie Argollo, et al.
Expert Opinion on Drug Safety|May 23, 2020
Long-term safety of approved biologics for ulcerative colitisFerdinando D'Amico, Tommaso Lorenzo Parigi, Stefanos Bonovas, et al.
Pageof 156